Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma

(2012) Daniel Keizman et al.   EUROPEAN JOURNAL OF CANCER

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

(2010) S. Patil et al.   ANNALS OF ONCOLOGY

Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib

(2010) B. Beuselinck et al.   ANNALS OF ONCOLOGY

Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer

(2010) Valentina Guarneri et al.   BREAST CANCER RESEARCH AND TREATMENT

Phase 3 trial of everolimus for metastatic renal cell carcinoma

(2010) Robert J. Motzer et al.   CANCER

A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer

(2010) Mohamed S. Zaghloul et al.   International Journal of Clinical Oncology

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

(2010) Gareth J Morgan et al.   LANCET

Zoledronic Acid Use in Patients With Bone Metastases From Renal Cell Carcinoma or Bladder Cancer

(2010) Fred Saad et al.   SEMINARS IN ONCOLOGY

Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?

(2009) J. Ayllon et al.   ANNALS OF ONCOLOGY

The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis

(2009) Kostantinos Zarogoulidis et al.   INTERNATIONAL JOURNAL OF CANCER

Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone

(2009) C. Christodoulou et al.   ONCOLOGY

Sorafenib for Metastatic Renal Cancer

(2008) Rachel P. Riechelmann et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

(2008) Robert J Motzer et al.   LANCET